ELF-1 Expression in Nasopharyngeal Carcinoma Facilitates Proliferation and Metastasis of Cancer Cells via Modulation of CCL2/CCR2 Signaling

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s196355
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Targeting the CCL2-CCR2 Signaling Axis in Cancer Metastasis

Oncotarget
Oncology
2016English

CCL2-CCR2 Axis Promotes Metastasis of Nasopharyngeal Carcinoma by Activating ERK1/2-MMP2/9 Pathway

Oncotarget
Oncology
2015English

LRG-1 Promotes Pancreatic Cancer Growth and Metastasis via Modulation of the EGFR/p38 Signaling

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

MicroRNA‑214 Promotes Proliferation and Inhibits Apoptosis via Targeting Bax in Nasopharyngeal Carcinoma Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Overexpression of CAPN2 Promotes Cell Metastasis and Proliferation via AKT/mTOR Signaling in Renal Cell Carcinoma

Oncotarget
Oncology
2017English

SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating WNT Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients

Journal of Histochemistry and Cytochemistry
AnatomyHistology
2018English

Estrogen Promotes Progression of Hormone-Dependent Breast Cancer Through CCL2-CCR2 Axis by Upregulation of Twist via PI3K/AKT/NF-κB Signaling

Scientific Reports
Multidisciplinary
2018English

MicroRNA Let-7 Suppresses Nasopharyngeal Carcinoma Cells Proliferation Through Downregulating C-Myc Expression

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2010English

NDRG1 Attenuates Epithelial–mesenchymal Transition of Nasopharyngeal Cancer Cells via Blocking Smad2 Signaling

Biochimica et Biophysica Acta - Molecular Basis of Disease
Molecular MedicineMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy